The SDCEP Prescribing Guidance is a clinical reference published by the Scottish Dental Clinical Effectiveness Programme that helps dentists in primary care make evidence-based decisions about which drugs to prescribe and when. First released in April 2008 under the title Drug Prescribing For Dentistry, the guidance has been updated to reflect changes in prescribing information and drug availability, with a second edition arriving in August 2011 and subsequent revisions since.1Nature. SDCEP Dental Prescribing app While the guidance covers a broad range of medications used in dental practice, its most consequential impact has been on antibiotic prescribing, where it provides clear criteria for when antimicrobials are genuinely warranted and when they are not.
What SDCEP Is and Why It Matters
The Scottish Dental Clinical Effectiveness Programme is a national body that sits within NHS Education for Scotland. Its job is to develop practical, evidence-based guidance that dental professionals can apply in everyday clinical settings. Unlike academic papers or textbook chapters, SDCEP publications are designed to be picked up and used at the point of care. They synthesize current research, regulatory changes, and expert consensus into concise recommendations that a general dental practitioner can follow during or between patient appointments.
The prescribing guidance is one of SDCEP’s most widely used outputs, but it is not the only one. SDCEP also produces guidance on topics like the management of patients taking anticoagulant or antiplatelet drugs, dental caries prevention, and oral health assessment.2British Dental Journal. Managing direct oral anticoagulants in accordance with the Scottish Dental Clinical Effectiveness Programme guidance for patients undergoing dentoalveolar surgery The prescribing guidance, though, holds a special place because drug prescribing touches nearly every area of dental care, from managing pain after an extraction to deciding whether a patient with a dental abscess needs an antibiotic or simply needs the abscess drained.
What the Guidance Covers
The prescribing guidance is not limited to antibiotics, even though antibiotics tend to dominate the conversation around it. The document addresses the full range of drugs a general dental practitioner might prescribe or recommend, including analgesics for pain relief, antifungal agents for oral thrush, antiseptic mouthwashes, anxiolytics for nervous patients, and emergency drugs that dental practices are expected to keep on hand. For each category, it offers recommendations on drug choice, dosage, duration, and situations where prescribing is or is not appropriate.
One of the guidance’s strengths is that it is written specifically for dentistry rather than adapted from general medical prescribing references. The British National Formulary covers dental prescribing in its own section, but SDCEP’s guidance goes further by contextualizing recommendations within the workflow and clinical scenarios that dentists actually face. A general practitioner writing a prescription for amoxicillin is operating in a very different context from a dentist deciding whether a patient with acute pulpitis needs amoxicillin at all, or whether the right move is a local procedure like extirpation or extraction. SDCEP’s guidance helps dentists navigate those decisions rather than defaulting to a prescription.
The Antibiotic Prescribing Problem in Dentistry
Antibiotic overprescribing in dentistry is a genuine public health concern, and it is the backdrop against which the SDCEP guidance has had its greatest influence. Dentists account for a meaningful share of all antibiotic prescriptions written in the UK. Many dental infections, particularly those involving the pulp of a tooth or a localized abscess, are best treated by removing the source of infection through drainage or extraction rather than by prescribing antibiotics. Antibiotics can reduce symptoms temporarily, but without definitive treatment of the underlying cause, the infection often returns.
The SDCEP guidance aims to assist dentists in making evidence-based antibiotic prescribing decisions, drawing clear lines between situations where antibiotics are justified and situations where they serve as a substitute for operative treatment.3BioMed Central / Implementation Science. Evaluating an audit and feedback intervention for reducing antibiotic prescribing behaviour in general dental practice (the RAPiD trial): a partial factorial cluster randomised trial protocol For instance, a patient with a localized dental abscess who is otherwise healthy and can receive treatment that day does not typically need antibiotics. A patient with spreading infection, systemic symptoms like fever and malaise, or significant immunocompromise may genuinely benefit from antimicrobial therapy. The guidance helps dentists distinguish between these scenarios rather than treating all infections identically with a prescription pad.
This distinction matters because antimicrobial resistance is driven in part by unnecessary antibiotic use. Every prescription that does not provide meaningful clinical benefit contributes to selection pressure on bacteria without delivering a corresponding patient benefit. Dental prescribing is far from the only contributor to resistance, but it is one that can be targeted with relatively clear guidelines because many dental infections have a mechanical solution that renders antibiotics redundant.
Why Dentists Sometimes Prescribe Outside the Guidance
Knowing what the guidance recommends and following it in every case are two different things. Research into dental prescribing patterns has identified several factors that push dentists toward prescribing antibiotics even when the clinical situation does not clearly call for them. An audit of antimicrobial prescribing by dentists in Wales found that practitioners pointed to failure of previous local treatment measures, patient unwillingness or inability to receive operative treatment at that appointment, direct patient demand for antibiotics, time pressures during busy clinic sessions, and complications arising from a patient’s medical history as influences on their prescribing behaviour.4British Dental Journal. Antimicrobial prescribing by dentists in Wales, UK: findings of the first cycle of a clinical audit
Some of these pressures are clinical and legitimate. A patient who presents on a Friday afternoon with a dental abscess but refuses extraction creates a genuine dilemma: the textbook answer is to treat the source of infection, but the patient will not consent. Prescribing an antibiotic to tide the patient over until they can be seen again or until they agree to definitive treatment is a pragmatic compromise, even if it is not the ideal recommended pathway. Similarly, a patient with a complex medical history involving immunosuppression or poorly controlled diabetes may warrant a lower threshold for antibiotic prescribing than a healthy adult with the same dental presentation.
Other pressures are less defensible. Patient demand for antibiotics is a well-documented driver of overprescribing across all healthcare settings, not just dentistry. Some patients arrive convinced that an antibiotic is what they need and are dissatisfied with any other answer. Time pressure is another factor: performing an incision and drainage or starting a root canal treatment takes longer than writing a prescription. In a packed schedule with limited appointment slots, the prescription can become the path of least resistance. The SDCEP guidance does not pretend these pressures do not exist, but it gives practitioners a clear reference point to return to and a professional standard to cite when explaining to patients why an antibiotic is not the best option.
Audit, Feedback, and Improving Compliance
Publishing guidance is only useful if practitioners actually change their behaviour in response to it. Recognizing this, researchers and policymakers have explored ways to reinforce the guidance through audit and feedback mechanisms. The RAPiD trial, for example, was designed specifically to evaluate whether structured audit and feedback could reduce unnecessary antibiotic prescribing in general dental practice.3BioMed Central / Implementation Science. Evaluating an audit and feedback intervention for reducing antibiotic prescribing behaviour in general dental practice (the RAPiD trial): a partial factorial cluster randomised trial protocol The underlying logic is straightforward: dentists receive data on their own prescribing patterns compared to the recommended standards in the SDCEP guidance, which creates a feedback loop. Practitioners who see that their prescribing rates are higher than the evidence supports can adjust, while those already aligned with the guidance get confirmation that their practice is on track.
Audit and feedback works partly because of a well-known gap between self-perception and reality. Many prescribers believe they follow guidelines more closely than they actually do. Without objective data, it is easy to remember the cases where you made the evidence-based choice and forget the ones where you defaulted to a prescription under time pressure. Structured audit closes that gap by presenting practitioners with their actual numbers. Combined with accessible guidance that makes the “right” decision clear, the approach has been shown across many healthcare settings to produce modest but real improvements in prescribing behaviour.
Managing Patients on Blood-Thinning Medications
Beyond antibiotic prescribing, SDCEP has produced specific guidance on managing dental patients who take anticoagulant or antiplatelet drugs. This is a separate but closely related document that addresses a common and sometimes anxiety-inducing clinical scenario. Patients taking medications like warfarin, rivaroxaban, apixaban, or clopidogrel present a challenge for dental procedures that involve bleeding, such as extractions, biopsies, or periodontal surgery. The concern is that these medications, which reduce the blood’s ability to clot, could lead to prolonged or difficult-to-control bleeding after a dental procedure.
The SDCEP guidance on this topic provides recommendations for managing patients taking direct oral anticoagulants, helping dental practitioners assess bleeding risk and decide whether a procedure can go ahead safely without altering the patient’s medication.2British Dental Journal. Managing direct oral anticoagulants in accordance with the Scottish Dental Clinical Effectiveness Programme guidance for patients undergoing dentoalveolar surgery For many routine dental extractions, the risk of stopping or reducing anticoagulant therapy outweighs the risk of post-operative bleeding, because interrupting these drugs can expose the patient to stroke or other thromboembolic events. The guidance helps dentists weigh these competing risks and take appropriate local haemostatic measures rather than reflexively referring patients to hospital or asking their physician to stop the medication.
This guidance has been particularly valuable as the use of direct oral anticoagulants has grown. Older anticoagulants like warfarin had established protocols for dental management, including INR testing before procedures. The newer agents work differently and do not have a simple blood test equivalent, which initially left many dental practitioners uncertain about how to proceed. SDCEP filled that gap with practical, stepwise recommendations.
How the Guidance Is Accessed
SDCEP has made a deliberate effort to make the prescribing guidance easy to use at the point of care. In addition to the printed and PDF versions of the guidance document, SDCEP developed a dedicated Dental Prescribing app.1Nature. SDCEP Dental Prescribing app The app allows practitioners to look up drug recommendations quickly during or between appointments, which addresses one of the practical barriers to guideline adherence: even well-intentioned clinicians may not follow guidance they cannot easily access in the moment they need it.
The shift to digital delivery also makes it easier to keep the guidance current. Drug prescribing information changes frequently as new products enter the market, existing drugs gain new indications or safety warnings, and evidence accumulates on best practices. A printed guide published in 2011 is inevitably out of date in some respects within a few years. A digital platform can be updated more readily, ensuring that the recommendations practitioners see reflect the current state of the evidence rather than a snapshot from the year the last edition went to print.
Relevance Beyond Scotland
Although SDCEP is a Scottish programme, its prescribing guidance is used and referenced well beyond Scotland’s borders. The audit of antimicrobial prescribing by dentists in Wales, for instance, used the SDCEP guidance as one of its reference standards for evaluating whether prescriptions were appropriate.4British Dental Journal. Antimicrobial prescribing by dentists in Wales, UK: findings of the first cycle of a clinical audit In England and Northern Ireland, dental practitioners may refer to SDCEP alongside resources from the Faculty of General Dental Practice and the relevant sections of the British National Formulary. The core clinical questions are the same regardless of geography: does this patient need an antibiotic, what drug and dose are appropriate, and when should I refer rather than prescribe?
The guidance has also influenced dental education. Training programmes across the UK incorporate SDCEP recommendations into their teaching on therapeutics and prescribing, which means newly qualified dentists often arrive in practice already familiar with the framework. This matters for long-term culture change around antibiotic stewardship, because practitioners who learn evidence-based prescribing habits early are less likely to develop the reflexive prescribing patterns that the guidance aims to correct.
Analgesic Recommendations and the Opioid Question
While antibiotics get the most attention, the prescribing guidance also addresses pain management in ways that have become increasingly relevant. For most dental pain, over-the-counter analgesics like ibuprofen and paracetamol are effective first-line options. The combination of the two, taken at alternating intervals, provides pain relief comparable to many stronger alternatives for post-extraction pain and similar acute dental conditions.
The guidance is cautious about opioid analgesics, recommending them only when non-opioid options are insufficient and typically for short durations. This is in line with broader efforts across healthcare to reduce unnecessary opioid prescribing. Dental procedures are one of the contexts where opioids have historically been prescribed for pain that non-opioid alternatives could manage perfectly well. The SDCEP framework gives practitioners a structured way to step through the analgesic ladder without jumping straight to stronger medications that carry dependence risk, which is especially relevant for younger patients undergoing wisdom tooth removal and similar procedures where post-operative pain, while real, is usually self-limiting over a few days.